Physiological focus on the erythropoietin-hepcidin-ferroportin axis

ISSN： 1205-7541

Source： Canadian Journal of Physiology and Pharmacology, Vol.91, Iss.5, 2013-01, pp. : 338-345

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Identification of Interfacial Residues Involved in Hepcidin-Ferroportin Interaction

Letters in Drug Design & Discovery, Vol. 11, Iss. 3, 2014-01 ,pp. : 363-374

Bentham Science Publishers

Access to resources Recommend Favorite

Down with the Erythropoietin. Long Live the Erythropoietin !

Current Drug Targets, Vol. 10, Iss. 10, 2009-10 ,pp. : 1028-1032

Bentham Science Publishers

Access to resources Recommend Favorite

Erythropoietin: From Hematopoiesis to Cardioprotection

By Meer Peter Lipsic Erik Gilst Wiek Veldhuisen Dirk

Cardiovascular Drugs and Therapy, Vol. 19, Iss. 1, 2005-01 ,pp. : 7-8

Springer Publishing Company

Access to resources Recommend Favorite

A neuroprotective derivative of erythropoietin that is not erythropoietic

By Doggrell Sheila A

Expert Opinion on Investigational Drugs, Vol. 13, Iss. 11, 2004-11 ,pp. : 1517-1519

Informa Healthcare

Access to resources Recommend Favorite

Cancer Patient Survival and Erythropoietin

By Glaspy John A.

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 3, Iss. 6, 2005-11 ,pp. : 796-804

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite